Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system attacks healthy tissues, causing inflammation and potential organ damage. As per the Centers for Disease Control and Prevention (CDC), more than 200,000 people in the United States are estimated to have SLE. According to the systemic lupus erythematosus epidemiology forecast by Expert Market Research, disease prevalence supports continued attention to autoimmune disorders and their management.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Systemic Lupus Erythematosus – Number of Cases by Year

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Systemic Lupus Erythematosus Epidemiology Forecast Report Coverage

Expert Market Research's “Systemic Lupus Erythematosus Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of systemic lupus erythematosus. It projects the future incidence and prevalence rates of systemic lupus erythematosus cases across various populations. The study covers age, gender, and type as major determinants of the systemic lupus erythematosus population. The report highlights patterns in the prevalence of systemic lupus erythematosus over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of systemic lupus erythematosus in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Systemic Lupus Erythematosus Understanding: Disease Overview

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease in which the immune system mistakenly attacks healthy tissues, causing inflammation and damage to multiple organs, including the skin, joints, kidneys, heart, lungs, and nervous system. Its development involves genetic susceptibility, hormonal influences, environmental exposures, and immune system dysfunction. The disease can follow periods of remission and flare-ups, with severity varying among patients. Common manifestations include fatigue, joint pain, skin rashes, and kidney involvement. SLE is a major form of systemic autoimmune disease, requiring long-term monitoring and individualized clinical management.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Region

India

High-Risk Population

Women, particularly those of childbearing age, and certain racial and ethnic populations have a higher risk of developing SLE. The disease can also affect men and children.

Key Diagnostic Method

Antinuclear antibody (ANA) blood testing, interpreted alongside symptoms, physical examination, and other laboratory findings. An ANA result alone does not establish an SLE diagnosis.

Major Risk Factor

Genetic susceptibility, hormonal influences, environmental exposures, and immune system dysfunction contribute to SLE development; no single factor explains all cases.

Major gap in the market

Delayed or missed diagnosis, challenges in recognizing varied symptoms, and the need for effective long-term disease control and prevention of organ damage.

Systemic Lupus Erythematosus Epidemiology Perspective

The systemic lupus erythematosus epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the systemic lupus erythematosus epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for systemic lupus erythematosus and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to the Centers for Disease Control and Prevention (CDC), approximately 204,000 people in the United States have systemic lupus erythematosus (SLE), including around 184,000 females and 20,000 males. Globally, the PACE Hospitals estimates an overall SLE prevalence of 43.7 per 100,000 people.

Gender-Specific Cases of the Disease

According to the Lupus Foundation of America, approximately 90% of people with lupus are women. The CDC similarly reports that women account for approximately nine out of every ten cases, highlighting the substantial gender disparity in disease prevalence.

Age-Specific Cases of the Disease

According to the CDC, women of childbearing age, particularly those aged 15–44 years, have the highest risk of developing SLE. The Lupus Foundation of America also identifies this age group as the period when most people with lupus develop the disease.

Ethnicity-Wise Cases of the Disease

According to the CDC, Black or African American, Hispanic, Asian, and American Indian and Alaska Native populations are more affected by SLE than White populations. Black and American Indian and Alaska Native women are two to three times more likely to develop lupus than White women.

Mortality and Survival Analysis of the Disease

According to Elizabeth C. Jury et al. (2023), cardiovascular disease remains the leading cause of mortality among people with SLE, while younger patients with juvenile-onset SLE face an increased relative risk of mortality. The CDC also reports higher lupus-related mortality rates among Black people than White people.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Type 1 SLE

Represents acute, objectively measurable inflammatory disease activity, including organ-threatening flares such as lupus nephritis, inflammatory arthritis, and acute skin manifestations. It represents the major disease-activity component requiring particular attention because of its potential for organ damage.

Type 2 SLE

Encompasses persistent symptoms such as fatigue, widespread pain, and cognitive difficulties that may continue even when acute inflammation is controlled. It represents a distinct, symptom-focused component of SLE rather than a formally established minor disease subtype.

Systemic Lupus Erythematosus – Number of Cases by Country

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Country-wise Systemic Lupus Erythematosus Epidemiology

The systemic lupus erythematosus epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to the Centers for Disease Control and Prevention, an estimated 204,000 people have SLE, including approximately 184,000 females and 20,000 males. Women aged 15–44 years have the highest risk of developing the disease. Black and American Indian and Alaska Native women are two to three times more likely to develop lupus than White women.

Germany

Increasing recognition of diagnosed cases, long-term disease monitoring needs, and differences in access to specialist care may influence the recorded SLE burden and demand for ongoing treatment in Germany.

France

Regional differences in population characteristics, disease distribution, and access to diagnosis may contribute to variations in the recorded SLE burden across metropolitan France and its overseas territories.

Italy

The higher burden among women, regional variation in diagnosed cases, and the need for long-term management of chronic disease may influence SLE-related healthcare demand across Italy.

Spain

Geographic differences between rural and urban populations, variation in case identification, and the greater disease burden among women may affect the distribution of SLE cases and healthcare requirements across Spain.

United Kingdom

According to Elizabeth C. Jury et al. (2023), SLE affects approximately one in 1,000 people in the United Kingdom and primarily affects women. The authors also identify cardiovascular disease as the leading cause of mortality among people with SLE.

Japan

According to Yokogawa et al. (2025), 74,277 patients met the study's SLE definition in Japan between April 2019 and March 2020. The estimated prevalence was 60 per 100,000 people, with prefectural estimates ranging from 47 to 102 per 100,000.

India

According to PACE Hospitals, the reported prevalence of SLE in India is approximately 3.2 per 100,000 people. The source notes that prevalence may be higher in urban areas and that more cases are being identified in tertiary care hospitals as urbanization continues.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

Systemic lupus erythematosus presents opportunities to improve early diagnosis and long-term disease management across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India. Its diverse clinical manifestations can delay recognition, while organ involvement, particularly lupus nephritis, increases the need for timely diagnosis and appropriate treatment. A key opportunity is strengthening access to rheumatology services, antibody testing, and routine organ monitoring. Further growth potential lies in biologic therapies and individualized treatment strategies for patients whose disease remains active despite conventional treatment, subject to country-specific approvals, reimbursement, and access.

Systemic Lupus Erythematosus: Treatment Overview

Systemic lupus erythematosus treatment aims to control inflammation, prevent disease flares, minimize organ damage, and improve quality of life. Hydroxychloroquine is commonly used as foundational therapy, while nonsteroidal anti-inflammatory drugs may help manage selected symptoms. Corticosteroids and immunosuppressants, including mycophenolate mofetil and azathioprine, may be prescribed according to disease severity and organ involvement. Biologic therapies, such as belimumab and anifrolumab, provide additional options for eligible patients with active disease. Treatment is individualized according to clinical manifestations, disease activity, and safety considerations, with targeted immunotherapy contributing to the expansion of treatment options.

Key Questions Answered

  • What is the current and projected burden of systemic lupus erythematosus across the 8 major markets?
  • Which countries across the 8 major markets account for the highest systemic lupus erythematosus patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of systemic lupus erythematosus across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of systemic lupus erythematosus across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of systemic lupus erythematosus across the 8 major markets?
  • How do major comorbidities and risk factors influence systemic lupus erythematosus epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of systemic lupus erythematosus across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the systemic lupus erythematosus landscape across the 8 major markets?
  • Which therapeutic areas linked to systemic lupus erythematosus are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the systemic lupus erythematosus epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on systemic lupus erythematosus epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for systemic lupus erythematosus across the 8 major markets?

Scope of the Systemic Lupus Erythematosus Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of systemic lupus erythematosus based on several factors.
  • Systemic Lupus Erythematosus Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The systemic lupus erythematosus report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Argentina Systemic Lupus Erythematosus Market

Brazil Systemic Lupus Erythematosus Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us